CymitQuimica logo
Cellules souche et Dérivés

Cellules souche et Dérivés

Les inhibiteurs de cellules souches sont des composés qui ciblent spécifiquement les voies de signalisation et les protéines impliquées dans le maintien, la différenciation et la prolifération des cellules souches. Ces inhibiteurs sont cruciaux pour comprendre la biologie des cellules souches et pour développer des stratégies visant à manipuler les cellules souches à des fins thérapeutiques, telles que la médecine régénérative et le traitement du cancer. En contrôlant le destin des cellules souches, ces inhibiteurs peuvent aider à orienter la différenciation des cellules souches en types cellulaires spécifiques ou à prévenir une croissance cellulaire indésirable. Chez CymitQuimica, nous offrons une sélection d'inhibiteurs de cellules souches de haute qualité pour soutenir vos recherches en biologie des cellules souches, biologie du développement et médecine régénérative.

Sous-catégories appartenant à la catégorie "Cellules souche et Dérivés"

Affichez 2 plus de sous-catégories

679 produits trouvés pour "Cellules souche et Dérivés"

Trier par

Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
produits par page.
  • (+)-ITD-1

    CAS :
    (+)-ITD-1 is an inhibitor of TGF-β, effectively inhibiting TGF-β2 with an IC50 of 0.46 μM. It promotes the degradation of the TGF-β type II receptor (TGFBR2) and the differentiation of cardiomyocytes. Additionally, it suppresses the formation of the mesoderm during the early differentiation of mouse embryonic stem cells (mESCs).
    Formule :C27H29NO3
    Couleur et forme :Solid
    Masse moléculaire :415.52
  • STAT3-IN-36

    CAS :
    <p>STAT3-IN-36 (compound 11g) is a tritarget inhibitor that selectively targets LRPPRC, STAT3, and CDK1, exhibiting potent anticancer activity. This compound binds to LRPPRC, STAT3, and CDK1, demonstrating more effective anticancer effects than those of TMF or Capecitabine. Additionally, STAT3-IN-36 exhibits an IC50 value of 1.8 μM in HGC27 cells.</p>
    Formule :C30H24F2N2O9S2
    Couleur et forme :Solid
    Masse moléculaire :658.65
  • JAK1/TYK2-IN-3


    JAK1/TYK2-IN-3, orally active, selectively inhibits TYK2 (IC50: 6 nM), JAK1 (37 nM), JAK2 (140 nM), JAK3 (362 nM), and has anti-inflammatory effects.
    Couleur et forme :Solid
  • AJI-100

    CAS :
    AJI-100 serves as a dual-target inhibitor, effectively blocking Aurora kinase A and JAK2, with respective IC50 values of 12.7 nM and 18.5 nM. It inhibits T cell mitosis and cell polarity by directly targeting Aurora kinase A and reduces STAT3 phosphorylation by inhibiting JAK2 activation, consequently diminishing the differentiation of TH1 and TH17 cells. This compound is utilized in researching immune response regulation and the prevention of graft-versus-host disease (GVHD).
    Formule :C17H14FN5O
    Couleur et forme :Solid
    Masse moléculaire :323.32
  • JAK3-IN-7

    CAS :
    JAK3-IN-7 is a potent and selective JAK3 inhibitor (IC50<0.01 μM) for the treatment of rejection in organ transplantation, graft-versus-host reaction after
    Formule :C17H20N6O
    Degré de pureté :98.81%
    Couleur et forme :Solid
    Masse moléculaire :324.38
  • AJI-214

    CAS :
    AJI-214 functions as a dual-target inhibitor that specifically blocks Aurora kinase A and JAK2. By directly inhibiting Aurora kinase A, AJI-214 prevents mitotic progression and cell polarity in T cells while concurrently suppressing JAK2 activation to reduce STAT3 phosphorylation. This inhibition decreases the differentiation of TH1 and TH17 cells. AJI-214 is utilized in research focused on the modulation of immune responses and the prevention of graft-versus-host disease (GVHD).
    Formule :C17H13ClFN5O
    Couleur et forme :Solid
    Masse moléculaire :357.77
  • Kartogenin sodium

    CAS :
    Kartogenin (KGN) sodium acts as an inducer of chondrogenic tissue formation (EC 50: 100 nM). It promotes chondrogenesis by binding to fibrin A, disrupting its interaction with the transcription factor core binding factor beta subunit (CBFβ), and modulating the CBFβ-RUNX1 transcriptional program. Additionally, Kartogenin sodium aids tendon-bone junction (TBJ) wound healing by stimulating collagen synthesis. It is extensively utilized in cell-free therapies for cartilage regeneration and protection, tendon-bone healing, wound healing, and limb development. The compound is also vital for cartilage repair, coordinating limb development, and osteoarthritis (OA) research [1] [2] [3] [4].
    Formule :C20H14NNaO3
    Masse moléculaire :339.32
  • Ten01


    Ten01 exhibits a 5.0 nM inhibition of JAK1 kinase.
    Formule :C18H20F6N4O
    Couleur et forme :Solid
    Masse moléculaire :422.37
  • JAK1/TYK2-IN-4

    CAS :
    JAK1/TYK2-IN-4 serves as a dual inhibitor targeting both JAK and TYK2, displaying IC50 values of 39 nM and 21 nM, respectively. It is also orally bioavailable [1].
    Formule :C17H23N7O
    Couleur et forme :Solid
    Masse moléculaire :341.41
  • (Rac)-SAG

    CAS :
    (Rac)-SAG, an isoform of SAG, is a potent Smoothened (Smo) receptor agonist (EC₅₀ = 3 nM; Kd = 59 nM) that activates the Hedgehog signaling pathway and counteracts Cyclopamine's inhibition of Smo [1] [2] [3].
    Formule :C28H28ClN3OS
    Couleur et forme :Solid
    Masse moléculaire :490.06
  • Tyk2-IN-14

    CAS :
    Tyk2-IN-14, a small molecule inhibitor of TYK2, is significant in treating inflammatory diseases and conditions linked to hypersecretion of IFNa and interferons [1].
    Formule :C22H21N9O2
    Couleur et forme :Solid
    Masse moléculaire :443.46
  • Tyk2-IN-17

    CAS :
    <p>Tyk2-IN-17 (compound 185) effectively inhibits TYK2 [1].</p>
    Formule :C20H20F2N8O
    Couleur et forme :Solid
    Masse moléculaire :426.42
  • Tyk2-IN-15

    CAS :
    <p>Tyk2-IN-15 (Compound 97) is a selective inhibitor of tyrosine kinase 2 (Tyk2) with an IC50 value ≤ 10 nM for Tyk2-JH2. It is utilized in the research of inflammatory and autoimmune diseases [1].</p>
    Formule :C21H25F2N7O
    Couleur et forme :Solid
    Masse moléculaire :429.47
  • CDD-1431

    CAS :
    <p>CDD-1431 is a highly selective BMPR2 kinase inhibitor with a Kiapp of 20.6 nM. It inhibits BRE reporter gene activity, exhibiting an IC50 of 4.87 μM. BMPs regulate cellular processes across various tissue types such as the kidneys, skeletal muscle, heart, and reproductive organs, and can induce ectopic bone formation.</p>
    Formule :C33H38N8O5S
    Couleur et forme :Solid
    Masse moléculaire :658.77
  • Tyk2-IN-10

    CAS :
    Tyk2-IN-10 acts as an inhibitor of the Tyrosine Kinase 2 (Tyk2)-mediated signaling pathway, which plays a role in inflammation regulation.
    Formule :C25H27N5O3
    Couleur et forme :Solid
    Masse moléculaire :445.51
  • Carboxylesterase-IN-3

    CAS :
    <p>Carboxylesterase-IN-3 is a potent inhibitor of Carboxylesterase Notum (IC50 ≤ 10 nM).Carboxylesterase-IN-3 has the potential to study cancer diseases.</p>
    Formule :C11H6Cl2N4OS
    Degré de pureté :97.49% - 98.47%
    Couleur et forme :Solid
    Masse moléculaire :313.16
  • Londamocitinib

    CAS :
    Londamocitinib (JAK1-IN-7) is a selective and potent JAK1 inhibitor with anti-inflammatory activity.
    Formule :C28H31F2N7O4S
    Degré de pureté :98.64% - 99.56%
    Couleur et forme :Solid
    Masse moléculaire :599.65
  • Aβ42-IN-1

    CAS :
    Aβ42-IN-1, compound 1v, is a novel, potent and orally active γ-secretase modulator (GSM).
    Formule :C29H27ClN4O2
    Degré de pureté :98%
    Couleur et forme :Solid
    Masse moléculaire :499
  • GSK-3β inhibitor 20

    CAS :
    GSK-3β inhibitor20 (compound 3A) is an effective inhibitor of GSK-3β, exhibiting an IC50 value of 74.4 nM.
    Formule :C22H21N5O2S
    Couleur et forme :Solid
    Masse moléculaire :419.50
  • DAPM

    CAS :
    DAPM (gamma-Secretase Inhibitor XVI) is a Notch pathway inhibitor with anticancer activity and antiproliferative effects.
    Formule :C20H20F2N2O4
    Degré de pureté :99.76%
    Couleur et forme :Solid
    Masse moléculaire :390.38